Ortivus

Ortivus EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Ortivus (ORTI B.ST) as of Nov 16, 2026 is -3.59. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -20.60 — a change of -82.55% (higher).

EV/FCF

-3.59

YoY

-82.55%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Ortivus is 2025 -3.59 . EV/FCF (Enterprise Value to Free Cash Flow) of Ortivus was 2024 -20.60 . It decreases by -82.55% higher compared to the previous year.

The Ortivus EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-135.79 SEK
Jan 1, 2019
-40.11 SEK
Jan 1, 2020
9.32 SEK
Jan 1, 2021
141.72 SEK
Jan 1, 2022
-13.06 SEK
Jan 1, 2023
-15.81 SEK
Jan 1, 2024
-20.60 SEK
Jan 1, 2025
-3.59 SEK
The Ortivus EV/FCF history
YEAREV/FCFYoY
-3.59-82.55%
-20.60+30.29%
-15.81+21.08%
-13.06-109.21%
141.72+1,421.12%
9.32-123.23%
-40.11-70.46%
-135.79+829.23%
-14.61-138.03%
38.43-378.12%
-13.82-136.40%
37.96—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ortivus Stock analysis

What does Ortivus do? Ortivus AB develops and sells clinical devices and systems, including MobiMed Smart, a decision support system for ambulance personnel to handle documentation, monitoring, and structured prehospital care. CoroNet is a mobile surveillance solution enabling patients to move freely under medical supervision while providing healthcare professionals with real-time monitoring data. The company offers additional services like support, implementation, training, and consulting. Its primary customers are ambulance services and emergency departments. Ortivus AB generates revenue through the sale of MobiMed Smart and CoroNet systems, along with associated services. Ambulance services and emergency departments purchase these products to improve prehospital care documentation and patient monitoring. The decision support system MobiMed Smart streamlines ambulance operations, while CoroNet enhances patient supervision in healthcare settings, addressing key needs for efficient medical response and care management. The company's revenue model relies on direct sales of its clinical systems and supplementary services to healthcare providers. MobiMed Smart targets ambulance personnel for prehospital care documentation, and CoroNet serves healthcare professionals needing mobile patient monitoring. These products are tailored to the specific operational requirements of ambulance services and emergency departments, ensuring alignment with their workflows and care standards. Ortivus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ortivus stock

EV/FCF (Enterprise Value to Free Cash Flow) of Ortivus is -3.59 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Ortivus changed from -20.60 to -3.59, representing a -82.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Ortivus since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Ortivus with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Ortivus

All Key Metrics — Ortivus